John D. Mendlein
2014
In 2014, John D. Mendlein earned a total compensation of $1.4M as Chief Executive Officer and Director at aTYR PHARMA.
Compensation breakdown
| Non-Equity Incentive Plan | $76,875 |
|---|---|
| Option Awards | $604,606 |
| Salary | $410,000 |
| Stock Awards | $268,089 |
| Other | $38,407 |
| Total | $1,397,977 |
Mendlein received $604.6K in option awards, accounting for 43% of the total pay in 2014.
Mendlein also received $76.9K in non-equity incentive plan, $410K in salary, $268.1K in stock awards and $38.4K in other compensation.
Rankings
In 2014, John D. Mendlein's compensation ranked 6,096th out of 13,032 executives tracked by ExecPay. In other words, Mendlein earned more than 53.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,096 out of 13,032 | 53rd |
Division Manufacturing | 2,210 out of 4,966 | 56th |
Major group Chemicals And Allied Products | 737 out of 1,686 | 56th |
Industry group Drugs | 574 out of 1,365 | 58th |
Industry Biological Products, Except Diagnostic Substances | 108 out of 236 | 54th |
Source: SEC filing on April 12, 2016.
Mendlein's colleagues
We found one more compensation record of an executive who worked with John D. Mendlein at aTYR PHARMA in 2014.
2014
David Weiner
aTYR PHARMA